From: CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects
First Author | Publication Year | Number of Leukemia Cases (male/female) | Number of Controls (male/female) | Number of AML cases | Type of controls | Median (or mean) age, (range) year (Cases/Controls) | Racial decent | Country |
---|---|---|---|---|---|---|---|---|
Balta | 2003 | 33 (19/14) | 185 (120/65) | 33 AML | Healthy controls (PB) | 8.7(1–17)/7.4(0.58-17) | Mixed | Turkey |
D'Alo | 2004 | 193 (107/86) | 273(147/126) | 193 AML | Healthy controls (PB) | 62(19–87)/60(19–90) | Caucasian | Italy |
Clavel | 2005 | 219 (129/90) | 105 (57/48) | 28 AML | Non-cancer controls (age,- gender-, hospital-, ethnicity-matched; HB) | NA(0–15)/NA(0–15) | Mixed | France |
Aydin-Sayitoglu | 2006 | 249 (143/106) | 140 (73/67) | 50 adult AML; 44 pediatric AML | Healthy controls (PB) | Adult:33(19–75); pediatric: 7.8(2–18)/28.7(16–59) | Caucasian | Turkey |
Bolufer | 2007 | 443 (223/190) | 454 (223/231) | 302 AML | Healthy controls (PB) | 39.48(0.8-84)/38.38(1–85) | Caucasian | Spain |
Jiang | 2008 | 98 (NA) | 120 (NA) | 98 AML | Healthy controls (age-, sex-matched; PB) | NA(16–68)/NA(16–68) | Asian | China |
Majumdar | 2008 | 110 (70/40) | 126 (54/72) | 110 AML | Healthy controls (PB) | 35(4–81)/30(8–73) | Asian | India |
Yamaguti | 2009 | 133 (70/63) | 133 (70/63) | 133 AML | Healthy controls (PB) | 47(11–89)/53(25–60) | Mixed | Brazil |
Bonaventure | 2012 | 493 (266/227) | 549 (292/257) | 51 AML | Healthy controls (age-, gender-matched; PB) | NA(0–15)/NA(0–15) | Caucasian | France |
Kim | 2012 | 415 (223/192) | 1700 (821/879) | 415 AML | Healthy controls (PB) | 50.5(15–86)/52.2(20–74) | Asian | Korea |